Page last updated: 2024-09-05

sk&f 107260 and tirofiban

sk&f 107260 has been researched along with tirofiban in 1 studies

Compound Research Comparison

Studies
(sk&f 107260)
Trials
(sk&f 107260)
Recent Studies (post-2010)
(sk&f 107260)
Studies
(tirofiban)
Trials
(tirofiban)
Recent Studies (post-2010) (tirofiban)
11001,210309427

Protein Interaction Comparison

ProteinTaxonomysk&f 107260 (IC50)tirofiban (IC50)
Integrin subunit alpha 2bRattus norvegicus (Norway rat)0.13
Integrin beta-3Homo sapiens (human)0.1184
Integrin alpha-V Homo sapiens (human)0.011
Integrin alpha-IIbHomo sapiens (human)0.1225
Integrin beta-3 Rattus norvegicus (Norway rat)0.13

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gretler, DD; Scarborough, RM1

Reviews

1 review(s) available for sk&f 107260 and tirofiban

ArticleYear
Platelet glycoprotein IIb-IIIa antagonists as prototypical integrin blockers: novel parenteral and potential oral antithrombotic agents.
    Journal of medicinal chemistry, 2000, Sep-21, Volume: 43, Issue:19

    Topics: Administration, Oral; Animals; Antibodies, Monoclonal; Clinical Trials as Topic; Drug Design; Fibrinolytic Agents; Humans; Injections; Integrins; Molecular Mimicry; Peptides; Platelet Glycoprotein GPIIb-IIIa Complex; Snake Venoms

2000